Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
CLINICAL STUDIES

PHASE III SAFETY EVALUATION OF CYCLOSPORINE 0.1% OPHTHALMIC EMULSION ADMINISTERED TWICE DAILY TO DRY EYE DISEASE PATIENTS FOR UP TO 3 YEARS

Cohen, Elisabeth J. MD

Author Information
Evidence-Based Ophthalmology: October 2006 - Volume 7 - Issue 4 - p 172-173
doi: 10.1097/01.ieb.0000212037.20074.70
  • Buy
© 2006 Lippincott Williams & Wilkins, Inc.